Inventor · disambiguated record
Alan X. Xiang
Also filed as: XIANG ALAN X · XIANG ALAN XIN
18 granted patents·10 pending applications·116 citations·filing 2004–2023
94Inventor score
Files withEFFECTOR THERAPEUTICS INC16ANADYS PHARMACEUTICALS INC6WEBBER STEPHEN E4AVERETT DEVRON R1RUEBSAM FRANK1
Top patents by PatentIndex Score
28 records- 0195US9382248B2Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2015·Granted Jul 5, 2016·14 cites·25 claims
- 0294US9669031B2MNK inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2016·Granted Jun 6, 2017·12 cites·20 claims
- 0392US7560544B23,5-Disubsitituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereofANADYS PHARMACEUTICALS INC·Filed 2005·Granted Jul 14, 2009·16 cites·12 claims
- 0489US9814718B2MNK inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2017·Granted Nov 14, 2017·5 cites·20 claims
- 0589US8097718B23,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereofWEBBER STEPHEN E·Filed 2009·Granted Jan 17, 2012·11 cites·31 claims
- 0689US7709448B2Prodrugs of 5-amino-3-(3′-deoxy-β-D-ribofuranosyl)-thiazolo[4,5-d]pyrimidin-2,7-dioneANADYS PHARMACEUTICALS INC·Filed 2007·Granted May 4, 2010·13 cites·8 claims
- 0788US10577378B2EIF4A-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2018·Granted Mar 3, 2020·6 cites·14 claims
- 0888US9957277B2eIF4A-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2016·Granted May 1, 2018·6 cites·14 claims
- 0987US7582626B25,6-dihydro-1H-pyridin-2-one compoundsANADYS PHARMACEUTICALS INC·Filed 2007·Granted Sep 1, 2009·13 cites·20 claims
- 1085US11130757B2Crystalline forms of MNK inhibitorsEFFECTOR THERAPEUTICS INC·Filed 2019·Granted Sep 28, 2021·2 cites·10 claims
- 1183US11440917B2EIF4A-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2020·Granted Sep 13, 2022·1 cites·19 claims
- 1282US2023295179A1Eif4a-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1379US11286268B1EIF4E-inhibiting compounds and methodsEFFECTOR THERAPEUTICS INC·Filed 2020·Granted Mar 29, 2022·1 cites·28 claims
- 1479US7943759B23-β-D-ribofuranosylthiazolo[4-5-d]pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2010·Granted May 17, 2011·3 cites·6 claims
- 1578US10793551B2Benzimidazole-indole inhibitors of Mnk1 and Mnk2EFFECTOR THERAPEUTICS INC·Filed 2018·Granted Oct 6, 2020·2 cites·16 claims
- 1677US2023071483A1Eif4a-inhibiting compounds and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1776US8883758B23,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereofWEBBER STEPHEN E·Filed 2013·Granted Nov 11, 2014·2 cites·12 claims
- 1876US7321033B23-B-D-ribofuranosylthiazolo [4,5-d] pyrimidine nucleosides and uses thereofANADYS PHARMACEUTICALS INC·Filed 2004·Granted Jan 22, 2008·7 cites·11 claims
- 1975US7528115B2Carbonate and carbamate prodrugs of thiazolo[4,5-d]pyrimidinesANADYS PHARMACEUTICALS INC·Filed 2007·Granted May 5, 2009·2 cites·15 claims
- 2075US2021338673A1Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2170US11952375B2Crystalline forms of Mnk inhibitorsEFFECTOR THERAPEUTICS INC·Filed 2021·Granted Apr 9, 2024·0 cites·6 claims
- 2266US2019209560A1Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 2363US2018085368A1Mnk inhibitors and methods related theretoEFFECTOR THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 2463US2023108594A1Eif4e-inhibiting compounds and methodsEFFECTOR THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2555US2012121541A13,5-disubstituted and 3,5,7-trisubstituted-3h-oxazolo and 3h-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereofWEBBER STEPHEN E·Filed 2012·Application pending·0 cites
- 2645US2008070852A13-Beta-D-Ribofuranosylthiazolo[ 4,5-D] Pyridimine Nucleosides and Uses ThereofAVERETT DEVRON R·Filed 2004·Application pending·0 cites
- 2741US2008214529A1SATURATED FUSED [1,2-b]PYRIDAZINONE COMPOUNDSRUEBSAM FRANK·Filed 2007·Application pending·0 cites
- 2839US2012321590A1Bridged polycyclic compoundsWEBBER STEPHEN E·Filed 2012·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Alan X. Xiang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →